Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination

Previous clinical and epidemiological studies have shown that over time antibody titers decrease, and they do not provide long-term mucosa protection against SARS-CoV-2 infection. Additionally, the increase in breakthrough infections that occur more frequently in the vaccinated than in the study par...

Descripción completa

Detalles Bibliográficos
Autores principales: Primorac, Dragan, Brlek, Petar, Matišić, Vid, Molnar, Vilim, Vrdoljak, Kristijan, Zadro, Renata, Parčina, Marijo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953558/
https://www.ncbi.nlm.nih.gov/pubmed/35335076
http://dx.doi.org/10.3390/vaccines10030442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953558/
https://www.ncbi.nlm.nih.gov/pubmed/35335076
http://dx.doi.org/10.3390/vaccines10030442

Ejemplares similares